Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Plos One|December 24, 2010
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancerInti Zlobec, Eva Karamitopoulou, Luigi Terracciano, et al.
World Journal of Gastroenterology|October 13, 2010
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patientsInti Zlobec, Francesca Molinari, Vittoria Martin, et al.
Human Pathology|November 11, 2003
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samplesAlessandro Lugli, Yvonne Forster, Philippe Haas, et al.
The Journal of Pathology|January 21, 2003
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1Alexandar Tzankov, Annette Zimpfer, Alessandro Lugli, et al.
Human Pathology|June 14, 2011
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancerEva Karamitopoulou, Inti Zlobec, Ioannis Panayiotides, et al.
International Journal of Cancer|March 22, 2016
Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancerAndreas Seeber, Gerold Untergasser, Gilbert Spizzo, et al.
BMC Cancer|September 16, 2022
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancerLuca Noti, José A Galván, Heather Dawson, et al.
American Journal of Clinical Pathology|December 6, 2006
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approachLuigi Tornillo, Alessandro Lugli, Inti Zlobec, et al.
International Journal of Cancer|October 30, 2013
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiencyHeather Dawson, José A Galván, Melina Helbling, et al.
Oncogene|August 16, 2023
Pathologists' first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: an international studyJulie E M Swillens, Iris D Nagtegaal, Sam Engels, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Plos One|December 24, 2010
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancerInti Zlobec, Eva Karamitopoulou, Luigi Terracciano, et al.
World Journal of Gastroenterology|October 13, 2010
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patientsInti Zlobec, Francesca Molinari, Vittoria Martin, et al.
Human Pathology|November 11, 2003
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samplesAlessandro Lugli, Yvonne Forster, Philippe Haas, et al.
The Journal of Pathology|January 21, 2003
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1Alexandar Tzankov, Annette Zimpfer, Alessandro Lugli, et al.
Human Pathology|June 14, 2011
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancerEva Karamitopoulou, Inti Zlobec, Ioannis Panayiotides, et al.
International Journal of Cancer|March 22, 2016
Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancerAndreas Seeber, Gerold Untergasser, Gilbert Spizzo, et al.
BMC Cancer|September 16, 2022
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancerLuca Noti, José A Galván, Heather Dawson, et al.
American Journal of Clinical Pathology|December 6, 2006
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approachLuigi Tornillo, Alessandro Lugli, Inti Zlobec, et al.
International Journal of Cancer|October 30, 2013
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiencyHeather Dawson, José A Galván, Melina Helbling, et al.
Oncogene|August 16, 2023
Pathologists' first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: an international studyJulie E M Swillens, Iris D Nagtegaal, Sam Engels, et al.
Pageof 19